The next US President Donald Trump’s nominee for health secretary, vaccine skeptic Robert Kennedy Jr., caused a storm in the pharmaceutical industry, sending stocks crashing. In my opinion, however, a place to buy was created in the sector.
Just because Trump wants to appoint someone to an office does not mean that person will get there. Different positions have different conditions, some must be approved by the US Congress, some must pass security clearance, etc. In addition, Trump’s mind may change in the next two months, and someone else may take the place of the currently appointed person.
Related stories
The lone black sheep in my portfolio, the Danish pharmaceutical giant Novo Nordisk has started to rapidly reduce its lag behind other stocks in anticipation of excellent quarterly results and positive results from a new drug study.
Sun Investment Group (SIG), a solar energy development group registered in Lithuania, offers secured bonds with a 2-year term and 11.5% annual interest during the public bond issue until November 22, with the aim of raising up to 8 million euros from investors.
Source: www.aripaev.ee
